1. Impact of BMI on cardiovascular events, renal function, and coronary artery calcification.
- Author
-
Russo D, Morrone LF, Errichiello C, De Gregorio MG, Imbriaco M, Battaglia Y, Russo L, Andreucci M, and Di Iorio BR
- Subjects
- Adult, Aged, C-Reactive Protein metabolism, Calcium blood, Cholesterol, LDL blood, Cohort Studies, Coronary Artery Disease blood, Coronary Artery Disease complications, Coronary Vessels metabolism, Coronary Vessels physiopathology, Diabetes Mellitus physiopathology, Disease Progression, Female, Glomerular Filtration Rate, Hemoglobins metabolism, Humans, Hypertension physiopathology, Male, Middle Aged, Parathyroid Hormone blood, Phosphorus blood, Proteinuria blood, Proteinuria complications, Renal Dialysis, Renal Insufficiency, Chronic blood, Renal Insufficiency, Chronic complications, Serum Albumin metabolism, Time Factors, Vascular Calcification blood, Vascular Calcification complications, Body Mass Index, Coronary Artery Disease physiopathology, Proteinuria physiopathology, Renal Insufficiency, Chronic physiopathology, Vascular Calcification physiopathology
- Abstract
Background/aims: High BMI increases the risk of cardiovascular events (CVEs) in the general population. Conflicting results have been reported on the role of BMI on CVEs and on decline of renal function in patients with chronic kidney disease not on dialysis (CKD). This study evaluates the impact of BMI on CVEs, dialysis initiation, and coronary artery calcification (CAC) in CKD patients., Methods: CKD patients were divided in normal-BMI and high-BMI patients. CVEs, initiation of dialysis, and extent and progression of CAC were assessed. Univariate and multivariable analysis were performed (adjustment variables: age, diabetes, hypertension, gender, CKD stage, serum concentration of hemoglobin, parathyroid hormone, calcium, phosphorus, albumin, C-reactive protein, LDL-cholesterol, total calcium score, 24-hour proteinuria). Patients were followed to the first event (CVE, dialysis) or for 2 years., Results: 471 patients were evaluated. A CVE occurred in 13.5 and 21.3% (p < 0.05) of normal-BMI and high-BMI patients, respectively. High BMI did not increase the risk for CVEs in univariate (HR: 1.86; 95% CI: 0.97-3.54; p = 0.06) or multivariable analysis (HR: 1.36; 95% CI: 0.57-3.14; p = 0.50). High BMI did not increase the risk for initiation of dialysis in univariate (HR: 0.96; 95% CI: 0.58-1.60; p = 0.9) or multivariable analysis (HR: 1.77; 95% CI: 0.82-3.81; p = 0.14). Adding the interaction term (between BMI and glomerular filtration rate) to other variables, the risk of dialysis initiation significantly increased (HR: 3.06; 95% CI: 1.31-7.18; p = 0.01) in high-BMI patients. High BMI was not a predictor of CAC extent or progression., Conclusions: High BMI was not a predictor of CVEs. High BMI increased the risk for dialysis initiation, but high BMI was not associated to CAC extent and progression. The presence of confounders may underestimate the impact of high BMI on dialysis initiation., (© 2014 S. Karger AG, Basel.)
- Published
- 2014
- Full Text
- View/download PDF